4//SEC Filing
Logomasini Mark 4
Accession 0000810084-13-000003
CIK 0000810084other
Filed
Jan 27, 7:00 PM ET
Accepted
Jan 28, 9:14 PM ET
Size
9.9 KB
Accession
0000810084-13-000003
Insider Transaction Report
Form 4
Logomasini Mark
Director
Transactions
- Purchase
Warrant to Purchase Common Stock
2011-12-29+39,474→ 78,948 totalExercise: $0.19From: 2011-12-29Exp: 2014-06-28→ BJCT Common Stock (39,474 underlying) - Purchase
Series H Convertible Preferred Stock
2013-01-24$0.04/sh+3,192,285$111,730→ 3,192,285 totalExercise: $0.04From: 2013-01-24→ BJCT Common Stock (3,192,285 underlying) - Disposition to Issuer
Warrant to Purchase Common Stock
2013-01-24−78,948→ 0 totalExercise: $0.19From: 2013-01-24Exp: 2013-01-24→ BJCT Common Stock (78,948 underlying)
Footnotes (3)
- [F1]Cancellation of Warrants pursuant to Convertible Debt conversion into 8,673 Series H Preferred Stock.
- [F2]No expiration date.
- [F3]Holdings: 11,173 shares of Series H Preferred Stock convertible into 3,192,285 shares of Common Stock.
Documents
Issuer
BIOJECT MEDICAL TECHNOLOGIES INC
CIK 0000810084
Entity typeother
Related Parties
1- filerCIK 0001480077
Filing Metadata
- Form type
- 4
- Filed
- Jan 27, 7:00 PM ET
- Accepted
- Jan 28, 9:14 PM ET
- Size
- 9.9 KB